Olfactory ability in the healthy population: Reassessing presbyosmia
| File | Size | Format | |
|---|---|---|---|
| 37008_1.pdf | 360Kb | Adobe PDF | View |
| Title | Olfactory ability in the healthy population: Reassessing presbyosmia |
|---|---|
| Author | Mackay-Sim, Alan; Johnston, Amy Nicole Burne; Owen, Caroline; Burne, Thomas Henry Johnston |
| Journal Name | Chemical Senses |
| Editor | Dr B W Ache |
| Year Published | 2006 |
| Place of publication | Oxford, UK |
| Publisher | Oxford University press |
| Abstract | Age-associated loss of olfactory function, or presbyosmia, has been described in many studies of olfactory ability. Presbyosmia has been ascribed to idiopathic causes despite recognition that many neurodegenerative diseases also induce loss of olfactory function and increase in incidence in the aged population. Often this olfactory loss is unnoticed or unreported by affected individuals. More effective olfactory function in women compared with men is another common feature of many studies of olfactory function. Here we report on normative data from an Australian population study (n = 942) that has been divided into 2 subpopulations and reassessed as (included) a population of healthy, nonmedicated, nonsmokers with no history of nasal problems (n = 485) and (excluded) a population of participants who were either medicated, smokers or had a history of nasal problems (n = 457). The "included" data set shows a strong relationship between self-reporting of olfactory sensitivity and olfactory function score. The included data set shows a small but significant decline in olfactory ability after 65 years of age and better olfactory function in females compared with males. Data from the excluded population show a marked decline in olfactory ability after 65 years of age, no difference between males and females, and a weak relationship between self-reporting of olfactory function and actual olfactory function. The power of this approach is that it provides a normative data set against which many factors such as medication schedules and pathological conditions can be compared. |
| Peer Reviewed | Yes |
| Published | Yes |
| Publisher URI | http://chemse.oxfordjournals.org/ |
| Alternative URI | http://dx.doi.org/10.1093/chemse/bjl019 |
| Copyright Statement | Copyright 2006 authors.This is an open access paper. http://creativecommons.org/licenses/by/3.0/ license that permits unrestricted use, provided that the paper is properly attributed. |
| Volume | 31 |
| Page from | 763 |
| Page to | 771 |
| ISSN | 0379-864X |
| Date Accessioned | 2006-07-27 |
| Date Available | 2009-05-27T08:35:34Z |
| Language | en_AU |
| Research Centre | Centre for Health Practice Innovation; Eskitis Institute for Drug Discovery |
| Faculty | Eskitis, Inst Cell&Molecular Therapies |
| Subject | PRE2009-Neurobiology |
| URI | http://hdl.handle.net/10072/13872 |
| Publication Type | Journal Articles (Refereed Article) |
| Publication Type Code | c1 |
Please use this identifier to cite this record: http://hdl.handle.net/10072/13872
Griffith University copyright notice
Copyright in individual works within the repository belongs to their authors or publishers. You may make a print or digital copy of a work for your personal non-commercial use. All other rights are reserved, except for fair dealings or other user rights granted by the copyright laws of your country.
Back to top